Delivery Order SPE2DB22D3102-SPE2DB25FL2UA
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,568.75 for IMOVAX Rabies Vaccine vials on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price contract, which is not set-aside, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $1,376.21 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of IMOVAX Rabies Vaccine vials. The contract, which is a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), requires completion by July 28, 2025. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order valued at $4,500.75 to AmerisourceBergen Drug Corp for IMOVAX Rabies Vaccine Vials on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,227.50 delivery order for IMOVAX Rabies Vaccine vials under a firm fixed-price contract type. This non-set-aside award was issued on July 31, 2025, with an ultimate completion date of August 1, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of IMOVAX Rabies Vaccine Vials with a ceiling value of $12,591.13 under a firm fixed-price contract type. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 20, 2025. This award was made without a set-aside designation, indicating it was competitively awarded. The delivery order...
- The Defense Logistics Agency awarded a Delivery Order valued at $4,315.56 to AmerisourceBergen Drug Corp for IMOVAX Rabies Vaccine Vials, with a firm fixed price contract type. The award was made on July 28, 2025, with an ultimate completion date of July 29, 2025. This delivery order represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract reflects DLA's ongoing pharmaceutical procurement needs...
- The Defense Logistics Agency awarded a delivery order valued at $3,341.25 to AmerisourceBergen Drug Corp for Imovax Rabies Vaccine vials on August 28, 2025, with a completion date of August 29, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $8,032.44 to AmerisourceBergen Drug Corp for the supply of IMOVAX Rabies Vaccine Vials. This firm fixed price contract, awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a routine medical supply procurement with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, reflecting the company's role as a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,682.50 to AmerisourceBergen Drug Corp for Imovax Rabies Vaccine Vials, with an ultimate completion date of August 20, 2025. This firm fixed-price delivery order, awarded on August 19, 2025, represents a non-competitive award under an existing contract vehicle. The vaccine will be supplied from AmerisourceBergen's facility in Conshohocken, Pennsylvania, supporting federal medical supply requirements, particularly for...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency for the supply of IMOVAX Rabies Vaccine vials, with a contract ceiling value of $3,118.50. The award, issued on August 13, 2025, is structured as a firm fixed-price delivery order with an ultimate completion date of August 14, 2025. Performance will take place at the contractor's facility in Conshohocken, Pennsylvania. This award was not designated as a set-aside contract and was competitively awarded...
- SPE2DB22D3102Indefinite Delivery Contract
- SPE2DB22D3102-SPE2DB25FL2UADelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,924.74 on August 29, 2025, for the supply of IMOVAX Rabies Vaccine Vials. The contract is competitively awarded with no set-aside designation and employs firm fixed price terms, with an ultimate completion date of September 2, 2025. Performance will take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company maintains an extensive portfolio of federal contract awards covering a comprehensive range of pharmaceutical products, vaccines, and medical supplies. The rabies vaccine delivery reflects the company's role as a key supplier within the DLA's Medical Supply Chain, providing essential medical commodities to support military healthcare programs. As a child contract under the larger SPE2DX vehicle, this delivery order contributes to DLA's pharmaceutical supply mission and demonstrates the company's capability to fulfill time-sensitive medical product requirements across the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 8/29/25 |